In Today's 8-K Filing From Wyeth (NYSE: WYE): With regard to our diet drug litigation involving the products REDUX and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE